375 related articles for article (PubMed ID: 30386330)
21. Myeloid-Derived Suppressor Cells in
Fresno M; Gironès N
Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
[TBL] [Abstract][Full Text] [Related]
22. Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression.
Garcia AJ; Ruscetti M; Arenzana TL; Tran LM; Bianci-Frias D; Sybert E; Priceman SJ; Wu L; Nelson PS; Smale ST; Wu H
Mol Cell Biol; 2014 Jun; 34(11):2017-28. PubMed ID: 24662052
[TBL] [Abstract][Full Text] [Related]
23. CD11b+Gr-1
Sendo S; Saegusa J; Okano T; Takahashi S; Akashi K; Morinobu A
Arthritis Rheumatol; 2017 Dec; 69(12):2314-2327. PubMed ID: 28805019
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection.
Pearl JE; Torrado E; Tighe M; Fountain JJ; Solache A; Strutt T; Swain S; Appelberg R; Cooper AM
Eur J Immunol; 2012 Dec; 42(12):3267-79. PubMed ID: 22890814
[TBL] [Abstract][Full Text] [Related]
25. Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.
Bian Z; Abdelaal AM; Shi L; Liang H; Xiong L; Kidder K; Venkataramani M; Culpepper C; Zen K; Liu Y
Eur J Immunol; 2018 Jun; 48(6):1046-1058. PubMed ID: 29488625
[TBL] [Abstract][Full Text] [Related]
26. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
27. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
Namdev P; Patel S; Sparling B; Garg A
Front Immunol; 2021; 12():647019. PubMed ID: 33995365
[TBL] [Abstract][Full Text] [Related]
28. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.
Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J
Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908
[TBL] [Abstract][Full Text] [Related]
29. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
[No Abstract] [Full Text] [Related]
30. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
[TBL] [Abstract][Full Text] [Related]
31. Cell-mediated immune response in swine infected with Mycobacterium avium subsp. avium.
Stepanova H; Pavlova B; Stromerova N; Matiasovic J; Kaevska M; Pavlik I; Faldyna M
Vet Immunol Immunopathol; 2011 Jul; 142(1-2):107-12. PubMed ID: 21592586
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic, morphological, and functional heterogeneity of splenic immature myeloid cells in the host response to tularemia.
Rasmussen JW; Tam JW; Okan NA; Mena P; Furie MB; Thanassi DG; Benach JL; van der Velden AW
Infect Immun; 2012 Jul; 80(7):2371-81. PubMed ID: 22526678
[TBL] [Abstract][Full Text] [Related]
33. Characterization of immune responses during infection with Mycobacterium avium strains 100, 101 and the recently sequenced 104.
Saunders BM; Dane A; Briscoe H; Britton WJ
Immunol Cell Biol; 2002 Dec; 80(6):544-9. PubMed ID: 12406388
[TBL] [Abstract][Full Text] [Related]
34. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
[TBL] [Abstract][Full Text] [Related]
35. Leptin deficiency in vivo enhances the ability of splenic dendritic cells to activate T cells.
Ramirez O; Garza KM
Int Immunol; 2014 Nov; 26(11):627-36. PubMed ID: 24966213
[TBL] [Abstract][Full Text] [Related]
36. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
Bruger AM; Dorhoi A; Esendagli G; Barczyk-Kahlert K; van der Bruggen P; Lipoldova M; Perecko T; Santibanez J; Saraiva M; Van Ginderachter JA; Brandau S
Cancer Immunol Immunother; 2019 Apr; 68(4):631-644. PubMed ID: 29785656
[TBL] [Abstract][Full Text] [Related]
37. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M
J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103
[TBL] [Abstract][Full Text] [Related]
38. M-MDSC
Aintablian A; Strozniak S; Heuer M; Lutz MB
Front Immunol; 2023; 14():1130600. PubMed ID: 37275910
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells.
Shime H; Maruyama A; Yoshida S; Takeda Y; Matsumoto M; Seya T
Oncoimmunology; 2017; 7(1):e1373231. PubMed ID: 29296526
[TBL] [Abstract][Full Text] [Related]
40. Induction and expression of protective T cells during Mycobacterium avium infections in mice.
Appelberg R; Pedrosa J
Clin Exp Immunol; 1992 Mar; 87(3):379-85. PubMed ID: 1544223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
